Table 6.
|
GI bleeding patients with cancer
|
|||||||||
|
All GI Ca
|
Esophageal Ca
|
Gastric Ca
|
Hepatic Ca
|
Biliary Ca
|
Gallbladder Ca
|
Pancreatic Ca
|
Small bowel Ca
|
Colorectal Ca
|
|
Mortality aOR (95%CI) | Endoscopy | 0.42 (0.38-0.46) | 0.42 (0.31-0.57) | 0.42 (0.32-0.54) | 0.36 (0.29-0.43) | 0.43 (0.28-0.66) | 0.71 (0.24-2.11) | 0.36 (0.29-0.44) | 1.19 (0.59-2.43) | 0.45 (0.38-0.54) |
Surgery | 0.97 (0.84-1.13) | - | 1.73 (1.00-3.00) | 1.30 (0.67-2.53) | - | - | 0.85 (0.49-1.48) | 2.26 (0.95-5.36) | 1.33 (1.09-1.62) | |
Trans-arterial embolization | 1.35 (1.02-1.80) | - | 1.46 (0.81-2.62) | 1.12 (0.55-2.30) | - | - | 0.98 (0.56-1.69) | - | 2.52 (1.23-5.15) | |
Radiation therapy | 0.55 (0.29-1.05) | - | - | - | - | - | - | - | - |
Bold values: Statistically significant (P < 0.05). Adjusted odds ratio with 95% confidence interval; empty cells indicate that analysis for the corresponding intervention was not performed due to the insufficient sample size; multivariate logistic regression of outcome (mortality) was performed using the backward stepwise method to determine statistically significant factors; variables included in the analysis: Age, female, race, income, acute kidney injury, chronic kidney disease, heart failure, cirrhosis and liver failure, intestinal infection, metastasis, chemotherapy and immunotherapy, radiation gastroenteritis, palliative care, hypovolemic shock, endoscopy, surgery, embolization, and radiation therapy. GI: Gastrointestinal. CI: Confidence interval; Ca: Cancer; OR: Odds ratio.